FindTrial
Sign In

Establishing a biobank for detecting clinical immune status

Establishing a biobank for detecting clinical immune status

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046960
Enrollment
Unknown
Registered
2021-06-04
Start date
2020-10-01
Completion date
Unknown
Last updated
2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor

Interventions

Tumor group and nontumor group:no

Sponsors

Jinshan Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 85 years; 2. Tumor patient samples: patients with tumors in the department of oncology; 3. general surgery: in addition to cancer, infection and immune-related diseases of general surgery patients; Obstetrics and Gynecology: Except for patients with cancer, infection and immune-related diseases.

Exclusion criteria

Exclusion criteria: Blood should be drawn 2 weeks after transfusion therapy.

Design outcomes

Primary

MeasureTime frame
The biomarker of immune cells;metabolite;—

Countries

China

Contacts

Public ContactWu Duojiao

Jinshan Hospital of Fudan University

wuduojiao@126.com+86 13764145925

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026